Brookstone Capital Management Decreases Stake in Anthem Inc (ANTM)
Brookstone Capital Management cut its holdings in Anthem Inc (NYSE:ANTM) by 21.6% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 1,089 shares of the company’s stock after selling 300 shares during the period. Brookstone Capital Management’s holdings in Anthem were worth $299,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Campbell & CO Investment Adviser LLC boosted its position in shares of Anthem by 24.0% during the second quarter. Campbell & CO Investment Adviser LLC now owns 1,548 shares of the company’s stock valued at $368,000 after purchasing an additional 300 shares in the last quarter. Atria Investments LLC boosted its position in shares of Anthem by 5.8% during the second quarter. Atria Investments LLC now owns 5,522 shares of the company’s stock valued at $1,314,000 after purchasing an additional 301 shares in the last quarter. Reliance Trust Co. of Delaware boosted its position in shares of Anthem by 8.0% during the second quarter. Reliance Trust Co. of Delaware now owns 5,958 shares of the company’s stock valued at $1,418,000 after purchasing an additional 440 shares in the last quarter. Assenagon Asset Management S.A. boosted its position in shares of Anthem by 382.2% during the second quarter. Assenagon Asset Management S.A. now owns 15,957 shares of the company’s stock valued at $3,798,000 after purchasing an additional 12,648 shares in the last quarter. Finally, Jabodon PT Co. bought a new stake in shares of Anthem during the second quarter valued at approximately $3,710,000. 86.81% of the stock is owned by institutional investors and hedge funds.
In other Anthem news, EVP Thomas C. Zielinski sold 7,826 shares of the business’s stock in a transaction on Wednesday, November 7th. The stock was sold at an average price of $289.71, for a total value of $2,267,270.46. Following the sale, the executive vice president now directly owns 29,466 shares of the company’s stock, valued at $8,536,594.86. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CAO Ronald W. Penczek sold 763 shares of the business’s stock in a transaction on Tuesday, September 4th. The stock was sold at an average price of $265.56, for a total value of $202,622.28. Following the completion of the sale, the chief accounting officer now directly owns 1,334 shares in the company, valued at $354,257.04. The disclosure for this sale can be found here. Insiders sold 23,773 shares of company stock worth $6,554,741 over the last three months. Corporate insiders own 0.31% of the company’s stock.
Anthem (NYSE:ANTM) last released its earnings results on Wednesday, October 31st. The company reported $3.81 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $3.70 by $0.11. Anthem had a return on equity of 13.99% and a net margin of 4.98%. The business had revenue of $22.98 billion for the quarter, compared to the consensus estimate of $22.85 billion. During the same period in the previous year, the company posted $2.65 earnings per share. The company’s revenue for the quarter was up 4.0% compared to the same quarter last year. On average, research analysts predict that Anthem Inc will post 15.65 EPS for the current year.
The business also recently announced a quarterly dividend, which will be paid on Friday, December 21st. Shareholders of record on Wednesday, December 5th will be issued a $0.75 dividend. This represents a $3.00 annualized dividend and a yield of 1.05%. The ex-dividend date is Tuesday, December 4th. Anthem’s dividend payout ratio (DPR) is 24.92%.
Several research firms recently weighed in on ANTM. Barclays restated an “overweight” rating and set a $300.00 price target (up from $270.00) on shares of Anthem in a research report on Thursday, November 1st. Citigroup lowered Anthem from a “buy” rating to a “neutral” rating and set a $162.00 price target on the stock. in a research report on Monday, September 10th. Jefferies Financial Group restated a “buy” rating and set a $316.00 price target on shares of Anthem in a research report on Friday, October 12th. Cowen began coverage on Anthem in a research report on Monday, September 17th. They set an “outperform” rating and a $318.00 price target on the stock. Finally, BMO Capital Markets lifted their price target on Anthem from $300.00 to $310.00 and gave the company a “buy” rating in a research report on Thursday, November 1st. Four investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. The company has an average rating of “Buy” and an average target price of $292.19.
TRADEMARK VIOLATION WARNING: This story was originally reported by TheOlympiaReport and is the property of of TheOlympiaReport. If you are viewing this story on another domain, it was illegally copied and republished in violation of United States and international copyright & trademark law. The legal version of this story can be accessed at https://theolympiareport.com/2018/11/11/brookstone-capital-management-decreases-stake-in-anthem-inc-antm.html.
Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets.
Featured Story: Stop Order
Want to see what other hedge funds are holding ANTM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Anthem Inc (NYSE:ANTM).
Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.